bioMérieux
bioMérieux's Overview
bioMérieux is a French multinational biotechnology company specializing in in vitro diagnostics. For over 60 years, bioMérieux has been a key player in public health and a contributor to progress in medicine, providing diagnostic solutions (systems, reagents, software, services) that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company primarily serves clinical applications, particularly in the diagnosis of infectious diseases, and industrial applications, such as the microbiological control of food, pharmaceuticals, and cosmetics.
Where is bioMérieux's Headquarters?
HQ Function
The Marcy l'Étoile campus serves as the company's global administrative, research and development, strategic decision-making center, and houses significant manufacturing capabilities for diagnostic reagents and instruments.
Notable Features:
The campus is expansive, featuring state-of-the-art BSL-2 and BSL-3 research laboratories for microbiology and molecular biology, automated high-throughput manufacturing lines for diagnostic reagents and systems, and modern administrative buildings designed to foster collaboration. It often includes green spaces and employee amenities reflecting its focus on science, sustainability, and well-being.
Work Culture:
The work culture at bioMérieux's headquarters is typically described as collaborative, innovative, and mission-driven, with a strong emphasis on scientific excellence and contributing to public health. Employees often highlight the international environment and opportunities for professional development.
HQ Significance:
The Marcy l'Étoile headquarters is significant as the historical heart of bioMérieux, where many of its foundational innovations were developed. Its location within the Lyon biotech cluster provides access to a rich ecosystem of talent, research institutions, and industry partners.
Values Reflected in HQ: The headquarters reflects bioMérieux's commitment to innovation, scientific rigor, global health, and long-term vision. The investment in advanced facilities underscores its dedication to pioneering diagnostic solutions.
Location:
bioMérieux operates globally with a direct presence in over 45 countries and serves more than 160 countries through a large network of distributors. This worldwide footprint enables the company to support a wide range of functions including research and development, manufacturing, sales and marketing, customer service, and technical support for its clinical and industrial diagnostic solutions across diverse geographical markets.
Street Address:
376 Chemin de l'Orme
City:
Marcy l'Étoile
State/Province:
Auvergne-Rhône-Alpes
Country:
France
bioMérieux's Global Presence
Durham, North Carolina/USA
Address: 100 Rodolphe Street, Durham, NC 27712, USA
To support and expand bioMérieux's presence in the North and South American markets, tailoring solutions to regional healthcare and industrial needs, and fostering collaborations within the vibrant Research Triangle Park ecosystem.
Shanghai/China
Address: 25/F, Tower A, Dawning Center, No. 500 Hongbaoshi Road, Changning District, Shanghai 201103, China
To drive growth and market penetration in the rapidly expanding Asia-Pacific healthcare and industrial sectors, adapting global strategies to local market dynamics and regulatory environments.
Salt Lake City, Utah/USA
Address: 510 W Arapeen Dr, Salt Lake City, UT 84108, USA
Serves as a critical center for innovation and production in molecular diagnostics, supporting global demand for rapid and comprehensive infectious disease testing.
Buying Intent Signals for bioMérieux
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of bioMérieux
As of April 2025, bioMérieux' leadership includes:
Investors of bioMérieux
bioMérieux has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past year, bioMérieux saw significant leadership evolution, highlighted by Pierre Boulud's appointment as CEO, succeeding Alexandre Mérieux who became full-time Chairman. The company also strengthened its executive team with key appointments in R&D, Quality & Regulatory Affairs, and North American Clinical Operations, alongside some departures, positioning itself for continued strategic execution.
Departures
New Appointments:
Technology (Tech Stack) used by bioMérieux
Discover the tools bioMérieux uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
bioMérieux Email Formats and Examples
bioMérieux commonly uses the email format combining the employee's first name and last name, separated by a dot, followed by '@biomerieux.com'. For example, an employee named Jane Doe would likely have the email address jane.doe@biomerieux.com. Variations might exist for common names or specific departments, but this is the most prevalent pattern.
first.last@biomerieux.com
Format
jane.doe@biomerieux.com
Example
90%
Success rate
News and media
bioMérieux Corporate Website • May 14, 2024
bioMérieux and Oxford Nanopore Announce Collaboration to Bring Nanopore Sequencing to the Infectious Disease Diagnostics Market
bioMérieux and Oxford Nanopore Technologies have entered into a collaboration to explore opportunities to bring nanopore sequencing to the infectious disease diagnostics market, aiming to deliver rapid and accurate results for improved patient care....more
bioMérieux Corporate Website • April 25, 2024
bioMérieux: First-Quarter 2024 Sales - Solid start to the year
bioMérieux reported first-quarter 2024 sales of €965 million, an organic growth of 9.0% year-over-year. The performance was driven by strong demand for clinical microbiology and industrial applications, confirming the company's full-year guidance....more
bioMérieux Corporate Website • February 28, 2024
bioMérieux: 2023 Full-Year Results - Strong business performance
bioMérieux announced its 2023 full-year results, with sales reaching €3.7 billion, up 6.6% organically. The company highlighted robust growth in microbiology and industrial applications, alongside strategic investments in R&D and manufacturing....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including bioMérieux, are just a search away.